Preclinical Services is located within PIRL and offers a range of services for biotechnology and pharmaceutical companies wishing to establish safety or efficacy of their investigational new drugs and devices in preparation for regulatory submission. Preclinical Services has conducted preclinical safety and efficacy testing since 2002. Contract research can be conducted to OECD Principles of Good Laboratory Practice (GLP).

Services include:

  • Product safety and efficacy testing
  • Acute and chronic toxicity studies
  • Range finding studies
  • Repeat dose studies
  • Pharmacokinetic studies
  • Analytical chemistry services
  • Consulting services
  • Surgical technique development
  • Animal models of human disease
  • Range of laboratory animals (specialising in large animals)
  • Imaging and surgical suites
  • Other services can be developed or outsourced upon request